Clinical Cancer Research The Science of Cancer Health Disparities
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Clinical Cancer Research 11, -, , . doi:
© 2008 American Association for Cancer Research

Right arrow Help viewing high resolution images
Right arrow Return to article
(Click the button above to download this figure into PowerPoint for use in presentations. Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Note: Users are permitted to download figures from AACR journals into PowerPoint for use in educational presentations, provided that the citation and copyright information are displayed on the slide. Commercial use of these images or reproduction of the images in any other form requires written permission from the AACR. For more information on permission requests, send an e-mail message to permissions{at}aacr.org.

Click on image to view larger version.



Fig. 6. Effect of BMS-354825 on cell invasion. Cells were plated onto Matrigel-coated filters in a modified Boyden chamber. Cells were allowed to attach and spread for 16 hours before the addition of 10 nmol/L (for HNSCC cells) or 50 nmol/L (for NSCLC cells) BMS-354825 to the upper chamber and conditioned medium to the lower chamber. After 24 hours, cells still in the upper chamber were removed and cells that had invaded through the Matrigel were stained and counted. In parallel, cells treated identically were assessed for viability and cell number with trypan blue. The average number of cells per field is expressed as a percentage of the control after normalizing for cell number. The concentration of BMS-354825 was lowered in this experiment to minimize its effect on the absolute cell number. In all cases, when treated samples are compared with corresponding controls, P < 0.05.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online